<DOC>
	<DOC>NCT01847391</DOC>
	<brief_summary>This is a phase 1, single-blind, randomized, placebo-controlled, multiple ascending dose study aimed to assess the safety, tolerability, and pharmacokinetics of GS-6615 in healthy subjects.</brief_summary>
	<brief_title>A Phase 1 Study to Assess the Safety,Tolerability, and Pharmacokinetics of GS-6615 in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Weight of at least 50 kg with body mass index (BMI) between 18 and 30 kg/m2 Female subjects must be of nonchildbearing potential as defined per the protocol Male subjects with female partners of childbearing potential must be using protocol acceptable methods of contraception Willing and able to comply with the requirements of the protocol and directions Willing to avoid consumption of grapefruit, grapefruit juice and Seville oranges Willing to avoid consumption of nicotine (including nicotine gum) and alcoholic beverages Ongoing or history of any medical or surgical condition that, in the judgment of the Investigator, might jeopardize the subject's safety or interfere with the study objectives History of meningitis or encephalitis, seizures, migraines, tremors, myoclonic jerks, sleep disorder, anxiety, syncope, head injuries or a family history of seizures Any abnormal ECG findings, abnormal laboratory value, or physical examination findings at Screening judged to be clinically significant Any abnormal neurological examination findings at Screening that is judged as clinically significant Hemoglobin &lt; 12 g/dL Serology test positive for HIV, or hepatitis B or C Positive urine drug test (including cotinine or ethanol) Use of systemic prescription medications or over the counter (OTC) medication, including multivitamins, and dietary and herbal supplement Use of any experimental or investigational drug or device within 30 days Female subjects who are of childbearing potential, pregnant or lactating Donation or loss of blood within 8 weeks and/or donation of plasma within 7 days History of drug or alcohol abuse Psychosocial or addictive disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Ischemic Heart Disease</keyword>
	<keyword>Heart Disease</keyword>
</DOC>